HIGHLIGHTS
- who: Emma Morrish from the InstitutTechnical University Site Munich, Munich, Germany have published the paper: Cytotoxic FCER1G+ innate-like T cells: new potential for tumour immunotherapy, in the Journal: (JOURNAL) of 10/05/2022
- future: As u03b1u03b2ILTCKs recognise still undefined non-mutated antigens which might also be expressed on normal tissue cells additional studies are required to define potential autoimmune side effects and related toxicities of engineered or IL-15 triggered overactivated u03b1u03b2ILTCKs. Since the majority of these experiments were completed in murine models future investigations will need to validate the applicability of u03b1u03b2ILTCK-based . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.